Thursday, 23 May 2013- Older, sicker men with non-aggressive prostate cancer had a significantly greater risk of dying of causes other than prostate cancer, a risk that increased with age at diagnosis and comorbidities, data from...
Posted by: JV
Wednesday, 22 May 2013- In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be...
Wednesday, 22 May 2013- Men with prostate cancer gained no obvious benefits from treatment with the dominant form of adjuvant radiation therapy as compared with an older, less expensive technique, an analysis of a government...
Monday, 20 May 2013- UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities - the patient-reported Total Illness Burden Index for Prostate...
Friday, 17 May 2013- The US Food and Drug Administration (FDA) has approved radium-223 dichloride (Xofigo) for treating bone metastases from castration-resistant prostate cancer, the agency announced. Its specific indication...
Friday, 17 May 2013- Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment.
A new...
Thursday, 16 May 2013- U.S. veterans exposed to the powerful herbicide Agent Orange had a significantly increased risk of high-grade prostate cancer, researchers found.
In a cohort of men who served in Vietnam, Agent Orange...
Wednesday, 15 May 2013- A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.
The test, which improves risk...
Wednesday, 15 May 2013- Continence post robotic assisted laparoscopic radical prostatectomy (RALP) is approximately 90% and many reconstructive techniques have been described to improve early continence.
T. T. Shah anc...
Monday, 13 May 2013- The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for...
Thursday, 9 May 2013- The volume of cases performed at an institution each year has a direct effect on the outcome of surgical procedures, and should always be considered when looking at the benefits of a technique, according to...
Wednesday, 8 May 2013- Patients with prostate cancer that has metastasized, or spread, to other parts of the body face a significantly higher risk of dying when visiting a hospital emergency department on the weekend instead of...
Tuesday, 7 May 2013- Prostate-specific antigen (PSA) testing for prostate cancer screening should proceed only after careful discussion of risks and harms with patients, and should target men ages 55 to 69, according to the...
Monday, 6 May 2013- M. Geybels and colleagues investigated associations between statin use begun before prostate cancer (PCa) diagnosis and PCa recurrence/progression and PCa-specific mortality (PCSM) in a prospective,...
Thursday, 2 May 2013- The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas...
Thursday, 2 May 2013- Intermittent androgen deprivation appears to be just as hard on relapsing or advanced prostate cancer as continuous dosing but easier on patients, a meta-analysis showed.
None of the nine studies comparing...
Wednesday, 1 May 2013- Despite official salvos against routine prostate-specific antigen (PSA) testing in asymptomatic men, a majority of MedPage Today readers prefer the test be ordered. The American College of Physicians...
Tuesday, 30 April 2013- Cancer is typically thought to develop after genes gradually mutate over time, finally overwhelming the ability of a cell to control growth. But a new closer look at genomes in prostate cancer by an...
Tuesday, 30 April 2013- Previously, the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-CaP) questionnaire and/or the physician-reported Charlson Comorbidity Index (CCI) have provided assessments of...
